Arteris (AIP) Expected to Announce Quarterly Earnings on Tuesday

05 May 2026, 11:30 by Renee Jackson · The Cerbat Gem

Arteris (NASDAQ:AIP – Get Free Report) is expected to issue its Q1 2026 results after the market closes on Tuesday, May 12th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $21.03 million for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $20.14 million for the quarter, compared to analysts’ expectations of $18.55 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Arteris Stock Up 4.0%

AIP traded up $1.16 during trading on Tuesday, reaching $30.01. 197,932 shares of the company were exchanged, compared to its average volume of 516,726. The company’s 50-day moving average is $18.51 and its two-hundred day moving average is $16.40. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -36.59 and a beta of 1.93. Arteris has a 12-month low of $6.64 and a 12-month high of $30.26.

Insider Activity

In other news, CEO K Charles Janac sold 70,000 shares of the stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $19.04, for a total transaction of $1,332,800.00. Following the transaction, the chief executive officer directly owned 9,119,071 shares in the company, valued at approximately $173,627,111.84. This represents a 0.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Bayview Legacy, Llc sold 70,000 shares of the stock in a transaction dated Wednesday, April 8th. The shares were sold at an average price of $19.04, for a total value of $1,332,800.00. Following the transaction, the insider owned 9,119,071 shares in the company, valued at $173,627,111.84. This trade represents a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 821,923 shares of company stock worth $15,545,051. 33.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Arteris

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. grew its position in Arteris by 28.0% during the 4th quarter. Invesco Ltd. now owns 17,499 shares of the company’s stock worth $271,000 after acquiring an additional 3,830 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new position in Arteris during the 4th quarter worth approximately $162,000. VestGen Advisors LLC bought a new position in Arteris during the 4th quarter worth approximately $218,000. Tudor Investment Corp ET AL bought a new position in Arteris during the 4th quarter worth approximately $2,473,000. Finally, Numerai GP LLC bought a new position in Arteris during the 4th quarter worth approximately $390,000. 64.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AIP has been the topic of a number of recent research reports. Rosenblatt Securities reissued a “buy” rating and set a $20.00 price objective on shares of Arteris in a report on Friday, February 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a report on Monday, April 20th. Northland Securities set a $24.00 price objective on Arteris in a report on Friday, February 13th. Finally, Wall Street Zen cut Arteris from a “buy” rating to a “hold” rating in a report on Saturday. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.17.

Check Out Our Latest Stock Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.